The toxicity of cell therapy: Mechanism, manifestations, and challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The toxicity of cell therapy: Mechanism, manifestations, and challenges

Published:2020-11-25 Issue:5 Volume:41 Page:659-667
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J Appl Toxicol

Author:

Jin Yongjia¹,Dong Yan²³,Zhang Jin⁴^ORCID,Sun Jingwei⁴,Liu Yarong⁴,Chen Yong²³

Affiliation:

1. Shanghai Electric Power Hospital Shanghai China

2. Department of Musculoskeletal Oncology Fudan University Shanghai Cancer Center Shanghai China

3. Department of Oncology Shanghai Medical College, Fudan University Shanghai China

4. Grit Biotechnology Shanghai China

Publisher

Wiley

Subject

Toxicology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jat.4100

Reference83 articles.

1. Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes

2. CD3 limits the efficacy of TCR gene therapy in vivo

3. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

4. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome;Arkader R.;Archives of Disease in Childhood,2006

5. Toxicity and management in CAR T-cell therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy in advanced gynecologic cancer;BMC Medicine;2024-05-20

2. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application;Frontiers in Immunology;2024-05-02

3. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells;Molecular Cancer;2023-08-30

4. Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology;Cancers;2023-06-05

5. Lymphodepletion and cellular immunotherapy;NK Cells in Cancer Immunotherapy: Successes and Challenges;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3